Notice of Closed Meeting, 1975-1976 [2021-00283]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 6 / Monday, January 11, 2021 / Notices
Control No. 9000–0153, Alternatives to
Government-Unique Standards.
William F. Clark,
Director, Office of Government-Wide
Acquisition Policy, Office of Acquisition
Policy, Office of Government-Wide Policy.
[FR Doc. 2021–00265 Filed 1–8–21; 8:45 am]
BILLING CODE 6820–EP–P
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—RFA–
CK–21–001, US Travelers Health
Research, Surveillance, Communication,
and Outreach Network; RFA–CK–21–
002, Emerging Infections Network—
Research for Preventing, Detecting, and
Managing Travelers who Acquire
Infectious Diseases Abroad; and RFA–
CK–21–003, Monitoring Cause-specific
School Absenteeism for Estimating
Community-wide Influenza and SARSCoV–2 Transmission; February 10–11,
2021, 10:00 a.m.—5:00 p.m., EST.
Teleconference, Centers for Disease
Control and Prevention, Room 1080, 8
Corporate Square Blvd., Atlanta, GA
30329 which was published in the
Federal Register on November 30, 2020,
Volume 85, Number 230, pages 76575–
76576.
The meeting is being amended to
change the meeting date to February 10,
2021. The meeting is closed to the
public.
jbell on DSKJLSW7X2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027, (404) 718–
8833, ganderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
22:36 Jan 08, 2021
Jkt 253001
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2021–00280 Filed 1–8–21; 8:45 am]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2021–00284 Filed 1–8–21; 8:45 am]
BILLING CODE 4163–18–P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–CK–21–
001, US Travelers Health Research,
Surveillance, Communication, and
Outreach Network; RFA–CK–21–002,
Emerging Infections Network—
Research for Preventing, Detecting,
and Managing Travelers who Acquire
Infectious Diseases Abroad; and RFA–
CK–21–003, Monitoring Cause-specific
School Absenteeism for Estimating
Community-wide Influenza and SARSCoV–2 Transmission; Amended Notice
of Meeting
VerDate Sep<11>2014
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
1975
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–PS–21–002, Implementation
Research Consortium to Accelerate
Impact of Health Department-Delivered
HIV Prevention Activities.
Date: March 23, 2021.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1080, 8 Corporate Square Boulevard,
Atlanta, Georgia 30329–4027.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027, (404) 718–
8833, ganderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
Funding Opportunity Announcement
(FOA), PAR 20–280, Cooperative
Research Agreements to the World
Trade Center Health Program (U01); and
RFA OH–21–004, Exploratory/
Developmental Grants Related to the
World Trade Center Health Program
(R21).
Dates and Times: March 16–17, 2021,
from 9:00 a.m.–6:00 p.m., EDT; and
March 18, 2021, from 9:00 a.m.–12:00
p.m., EDT.
Place: Virtual.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Marilyn Ridenour, B.S.N., M.B.A.,
M.P.H., C.P.H., C.I.C., CAPT, USPHS,
Scientific Review Officer, CDC, National
E:\FR\FM\11JAN1.SGM
11JAN1
1976
Federal Register / Vol. 86, No. 6 / Monday, January 11, 2021 / Notices
Institute for Occupational Safety and
Health, 1095 Willowdale Road, Mailstop
1811, Morgantown, West Virginia
26505, Telephone: (304) 285–5879.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–00283 Filed 1–8–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP–21–001, Promoting the
Importance of Infant and Childhood
Vaccination Among Pregnant Women by
Prenatal Care Providers; and RFA–IP–
21–002, US Enhanced Surveillance
Network to Assess Burden, Natural
History, and Effectiveness of Vaccines to
Prevent Enteric and Respiratory Viruses
in Children.
Date: April 13–14, 2021.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
22:36 Jan 08, 2021
Jkt 253001
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Marilyn Ridenour B.S.N., M.B.A.,
M.P.H., C.P.H., C.I.C., CAPT, USPHS,
Scientific Review Officer, CDC, National
Institute for Occupational Safety and
Health, 1095 Willowdale Road, Mailstop
1811, Morgantown, West Virginia
26505, Telephone: (304) 285–5879.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–00281 Filed 1–8–21; 8:45 am]
[FR Doc. 2021–00285 Filed 1–8–21; 8:45 am]
BILLING CODE 4163–18–P
Notice of Closed Meeting
VerDate Sep<11>2014
1080, 8 Corporate Square Boulevard,
Atlanta, Georgia 30329–4027.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027, (404) 718–
8833, ganderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
Funding Opportunity Announcement
(FOA), RFA OH–21–003, Extension of
the World Trade Center Health Registry
(U50).
Date: April 13, 2021.
Time: 9:00 a.m.–6:00 p.m., EDT.
Place: Virtual.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP–21–003, Collaborative Research
on Influenza, Coronavirus Disease 2019
(COVID–19), and Other Respiratory
Pathogens in South Africa.
Date: May 13, 2021.
Time: 10:00 a.m.–5:00 p.m., EDT.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 86, Number 6 (Monday, January 11, 2021)]
[Notices]
[Pages 1975-1976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00283]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--Funding Opportunity Announcement
(FOA), PAR 20-280, Cooperative Research Agreements to the World Trade
Center Health Program (U01); and RFA OH-21-004, Exploratory/
Developmental Grants Related to the World Trade Center Health Program
(R21).
Dates and Times: March 16-17, 2021, from 9:00 a.m.-6:00 p.m., EDT;
and March 18, 2021, from 9:00 a.m.-12:00 p.m., EDT.
Place: Virtual.
Agenda: To review and evaluate grant applications.
FOR FURTHER INFORMATION CONTACT: Marilyn Ridenour, B.S.N., M.B.A.,
M.P.H., C.P.H., C.I.C., CAPT, USPHS, Scientific Review Officer, CDC,
National
[[Page 1976]]
Institute for Occupational Safety and Health, 1095 Willowdale Road,
Mailstop 1811, Morgantown, West Virginia 26505, Telephone: (304) 285-
5879.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-00283 Filed 1-8-21; 8:45 am]
BILLING CODE 4163-18-P
